The global interventional cardiology market is expected to grow at a CAGR of 11.1% in the first half of the forecast period and CAGR of 16.9% in the second half of the forecast period. The market is expected to grow at a CAGR of 15.0% from 2017 to 2027. The market is estimated at $13,920m in 2021 and $35,537m in 2027.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 225-page report you will receive 111 charts – all unavailable elsewhere.
The 225-page report provides clear detailed insight into the global interventional cardiology market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Global Interventional Cardiology Market forecasts from 2017-2027
• Percutaneous Coronary Intervention (PCI) submarket forecasts from 2017-2027, further segmented into:
– Drug-eluting Stents (DES)
– Bare Metal Stents
– Bioresorbable Stents
This section also discusses the leading products, competitive landscape, market share of the leading players, drivers & restraints, pipeline analysis, SWOT analysis, reimbursement schemes for PCI in the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China and India.
• Transcatheter Aortic Valve Implantation (TAVI/TAVR) from 2017-2027
This section also discusses the market share of the leading players, drivers & restraints, pipeline analysis, SWOT analysis, reimbursement schemes for TAVI/TAVR in the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China and India.
• Trans Mitral Valve Implantation (TMVR) submarket forecasts from 2017-2027
This section also discusses the market share of the leading players, drivers & restraints, pipeline analysis, SWOT analysis, reimbursement schemes for TMVR in the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China and India.
• Interventional Cardiology Leading National Market forecasts from 2017-2027 covering the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China, India and the Rest of the World (RoW)
Each country is further segmented into PCI, TAVI and TMVR.
• Assessment of selected leading companies that hold major market shares in the interventional cardiology market
• SWOT and STEP analysis of the global interventional cardiology market
Visiongain’s study is intended for anyone requiring commercial analyses for the Global Interventional Cardiology Market. You find data, trends and predictions.
Buy our report today Global Interventional Cardiology Market 2017-2027: Percutaneous Coronary Intervention (PCI), Transcatheter Aortic Valve Implantation (TAVI), Transcatheter Mitral Valve Implantation (TMVR).
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 Global Interventional Cardiology Market Overview
1.2 World Interventional Cardiology Market Segmentation
1.3 Overview of Findings
1.4 Structure of the Report
1.5 Why You Should Read This Report
1.6 How this Report Delivers
1.7 Key Questions Answered by this Analytical Report
1.8 Who is this Report For?
1.9 Research Methodology
1.9.1 Primary Research
1.9.2 Secondary Research
1.9.3 Market Evaluation & Forecasting Methodology
1.10 Frequently Asked Questions
1.11 Associated Visiongain Reports:
1.12 About Visiongain
2. Introduction to Interventional Cardiology
2.1 An Introduction to Interventional Cardiology Market
2.2 Coronary Artery Disease:
2.2.1 Medical Procedures and Surgical Interventions for treatment of CAD:
2.2.2 Percutaneous Coronary Intervention (PCI):
2.2.3 Evolution of Interventional Cardiology
2.3 Aortic Stenosis
2.3.1 Definition:
2.3.2 Medical Procedures and Surgical Interventions for treatment of Aortic Stenosis (AS):
2.3.3Evolution of Trans Aortic Valve Implantation
2.4 Mitral Valve Regurgitation
2.4.1 Medical Procedures and Surgical Interventions for treatment of Mitral Regurgitation (MR):
2.4.2 Evolution of Trans Mitral Valve Repair
3. Interventional Cardiology: World Market 2017-2027
3.1 Interventional Cardiology: World Market Overview, 2016
3.2 The World Interventional Cardiology Market
3.3 World Interventional Cardiology Market: Sales and Forecast 2017-2027
3.4 Changing Market Shares by Segment 2017-2027
3.5 World Interventional Cardiology Drivers and Restraints, 2017-2027
4. Percutaneous Coronary Intervention: World Market (PCI) 2017-2027
4.1 Percutaneous Coronary Intervention (PCI): Global Market Overview, 2016
4.2 The Global Percutaneous Coronary Intervention (PCI): Global Market Overview, 2016
4.3 The Global Percutaneous Coronary Intervention (PCI): Global Market Overview, 2016
4.4 The Global Percutaneous Coronary Intervention (PCI): Global Market by Type of Stents and Changing Market Shares, 2016
4.5 Competitive Landscape (Market share Analysis (%), 2015)
4.6 Market Dynamics of PCI Market, 2015
4.7 Pipeline Analysis of PCI Market, 2015 to 2027
4.7.1 New Technological Innovations to revive the mature coronary stents market
4.7.2 Greater Effectiveness of Bioasorbable Vascular Scaffolds
4.7.3 Strong R&D Pipeline: To Drive the Market Growth
4.7.4 Rising Prevalence of Coronary Artery Disease
4.7.5 Use of Bioresorbable vascular scaffolds for treatment of CAD
4.7.6 Dominance of major players is a major barrier for new and small entrants
4.7.7 Lack of reimbursement for certain PCI segments restricts the market growth
4.7.8 Competition from drug manufacturers
4.7.9 DES stent manufacturers may face internal competition from BVS manufacturers
4.8 Reimbursement for PCI
4.8.1 US PCI Reimbursement
4.8.2 Germany PCI Reimbursement
4.8.3 France PCI Reimbursement
4.8.4 Italy PCI Reimbursement
4.8.5 Spain PCI Reimbursement
4.8.6 UK PCI Reimbursement
4.8.7 Japan PCI Reimbursement
4.8.8 Australia PCI Reimbursement
4.8.9 Singapore PCI Reimbursement
4.8.10 China PCI Reimbursement
4.8.11 India PCI Reimbursement
5. Trans Aortic Valve Implantation (TAVI/ TAVR): World Market 2017-2027
5.1 Trans Aortic Valve Implantation (TAVI/TAVR): Global Market Overview, 2016
5.2 Competitive Landscape (Market share Analysis (%), 2015)
5.3 Market Dynamics of TAVR Market, 2016
5.4 SWOT Analysis of TAVR Market, 2016
5.4.1 New Technological Innovations are driving the TAVR market
5.4.2 Growing Favourable Reimbursement to provide an impetus for TAVR penetration
5.4.3 Growing adoption in Emerging market
5.4.4 Application of TAVR devices in intermediate and low risk patients
5.4.5 Need for trained interventional cardiologists
5.4.6 High cost of the TAVR device and procedure
5.4.7 Surgical Valve implant procedures
5.4.8 New market entrants with differentiated products
5.5 TAVR Pipeline Products – 2016-2027
5.6 Reimbursement for TAVR
5.6.1 US TAVR Reimbursement:
5.6.2 Germany TAVR Reimbursement:
5.6.3 France TAVR Reimbursement:
5.6.4 Italy TAVR Reimbursement:
5.6.5 UK TAVR Reimbursement:
5.6.6 Spain TAVR Reimbursement:
5.6.7 Japan TAVR Reimbursement:
5.6.8 Australia TAVR Reimbursement:
5.6.9 Singapore TAVR Reimbursement:
5.6.10 China TAVR Reimbursement:
5.6.11 India TAVR Reimbursement:
6. Trans Mitral Valve Implantation (TMVR): World Market 2017-2027
6.1 Trans Mitral Valve Implantation (TMVR): Global Market Overview, 2016
6.2 Competitive Landscape (Market share Analysis (%), 2015)
6.3 Market Dynamics of TMVR Market, 2016
6.4 SWOT Analysis of TMVR Market, 2016
6.4.1 New Technological Innovations
6.4.2 Encouraging reimbursement policies
6.4.3 Application of TMVR devices in Functional Mitral Regurgitation patients
6.4.4 Regulatory Approvals outside US and Europe
6.4.5 Financial hurdles cripple the market growth
6.4.6 Product recall and lack of trained surgeons may stymie the growth
6.4.7 Surgical Valve implant procedures
6.4.8 New market entrants with complementary products
6.5 TMVR Pipeline Analysis 2016-2027
6.6 Reimbursement for TMVR
6.6.1 US TMVR Reimbursement:
6.6.2 Germany TMVR Reimbursement:
6.6.3 France TMVR Reimbursement:
6.6.4 Italy TMVR Reimbursement:
6.6.5 UK TMVR Reimbursement:
6.6.6 Spain TMVR Reimbursement:
6.6.7 Japan TMVR Reimbursement:
6.6.8 Australia TMVR Reimbursement:
6.6.9 Singapore TAVR Reimbursement:
6.6.10 China TMVR Reimbursement:
6.6.11 India TMVR Reimbursement:
7. Leading National Markets 2017-2027
7.1 Geographical Breakdown of Interventional Cardiology Market
7.2 How will the regional market shares change by 2027?
7.3 The U.S. Interventional Cardiology Market 2017-2027
7.3.1 US Interventional Cardiology Market: Trends and Developments
7.4 Germany Interventional Cardiology Market 2017-2027
7.5 France Interventional Cardiology Market 2017-2027
7.6 Italy Interventional Cardiology Market 2017-2027
7.7 Spain Interventional Cardiology Market 2017-2027
7.8 UK Interventional Cardiology Market 2017-2027
7.9 Japan Interventional Cardiology Market 2017-2027
7.10 Australia Interventional Cardiology Market 2017-2027
7.11 Singapore Interventional Cardiology Market 2017-2027
7.12 China Interventional Cardiology Market 2017-2027
7.13 India Interventional Cardiology Market 2017-2027
7.14 Rest of World (RoW) Interventional Cardiology Market 2017-2027
8. Company Profiles
8.1 Abbott Vascular
8.1.1 Abbott Vascular: Interventional Cardiology Product Portfolio
8.1.2 Abbott Vascular: Financial Overview
8.1.3 List of Product approvals
8.1.4 Recent Developments
8.2 Edwards Lifesciences
8.2.1 Edwards Lifesciences Product Portfolio:
8.2.2 Edwards Lifesciences: Financial Overview:
8.2.3 Recent Developments
8.3 Medtronic Plc
8.3.1 Medtronic’s Product Portfolio
8.3.2 Medtronic’s Financial Overview
8.3.3 Medtronic’s Recent Developments
8.4 Boston Scientific
8.4.1 Boston Scientific Product Portfolio
8.4.2 Boston Scientific Financial Overview
8.4.3 Recent Developments:
8.5 Sysmetis
8.5.1 Financial Overview:
8.5.2 Product Portfolio:
8.6 Cardiac Dimensions
8.6.1 Financial Overview:
8.6.2 Product Portfolio:
8.6.3 Recent Developments:
8.6.4 Direct Flow Medical Inc.
8.6.5 Product Portfolio:
8.6.6 Financial Overview
9. SWOT and STEP Analysis of the Interventional Cardiology Market 2017-2027
9.1 Strengths
9.1.1 Product innovation
9.1.2 Strong distribution network
9.1.3 Robust R&D
9.1.4 Brand Image
9.2 Weaknesses
9.2.1 High costs of the devices
9.2.2 Lack of effective reimbursement
9.2.3 Delayed regulatory approvals
9.3 Opportunities
9.3.1 Leverage the established market presence
9.3.2 To tap the unmet needs of the industry
9.4 Threats
9.4.1 Intense competition from small players engaged in price wars for PCI market
9.4.2 New entrants in TMVR and TAVR market can pose threat for big players
9.5 Social
9.6 Technological
9.7 Political/ Legal
10. Pipeline Analysis of Interventional Cardiology Market, 2016 to 2027
10.1 PCI Market Pipeline Products – 2016-2027
10.2 TAVR Pipeline Products – 2016-2027
10.3 TMVR Pipeline Analysis 2016-2027
11. Recommendations & Conclusions
11.1 The World Interventional Cardiology Market 2016 and 2017
11.2 Current Leading Interventional Cardiology Segments
11.3 Leading Interventional Cardiology Companies
11.4 Leading Countries for Interventional Cardiology
11.5 World Interventional Cardiology Market Forecast 2017-2027
11.6 The Future of Interventional Cardiology Market Forecast 2017-2027
Some Associated Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form
List of Tables
Table 1.1 (Sample) Global Interventional Cardiology Market: Revenue ($m), AGR (%), CAGR (%) by Country, 2016-2027
Table 3.1 Global Interventional Cardiology Market: Revenue ($m) and Market Share (%) by Segment, 2016
Table 3.2 Global Interventional Cardiology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2016-2027
Table 4.1 Global Percutaneous Coronary Stent Market: Revenue ($m) and Market Share (%) by Segment, 2016
Table 4.2 Global Percutaneous Coronary Stent Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2016-2027
Table 4.3 List of Companies, their Stent System and Type of Polymer used
Table 4.4 Pipeline Analysis of PCI Market, 2015-2027
Table 4.5 SWOT Analysis of PCI Market,2015-2027
Table 5.1 Global TAVR Market Forecast: Revenue ($m), AGR (%) & CAGR (%), 2016-2027
Table 5.2 SWOT Analysis of TAVR Market,2016
Table 5.3 Technological Innovations of Interventional Cardiology Product
Table 5.4 Upcoming Interventional Cardiology Medical Imaging Technologies
Table 5.5 TAVR Product Pipeline, 2015-2020
Table 5.6 TAVR Product Pipeline, 2015-2020
Table 6.1 Global Trans-Mitral Valve Market (TMVR) Forecast: Revenue ($m), AGR (%) and CAGR (%), 2016-2027
Table 6.2 SWOT Analysis of TMVR Market, 2015-2027
Table 6.3 TMVR Product Pipeline Analysis, 2015-2027
Table 6.4 Transcatheter mitral valve repair technology under development, 2016-2027
Table 6.5 Transcatheter mitral valve repair technology under development, 2016-2027
Table 7.1 Global Interventional Cardiology Market by Country: Revenue ($m) and Market Share (%) by Segment, 2016
Table 7.2 Projections of Crude CVD Prevalence (%), 2010-2030 in the United States
Table 7.3 US Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.4 US Interventional Cardiology Market Forecast: Revenues ($m), by Segment, AGR (%) and CAGR (%), 2016-2027
Table 7.5 Germany Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.6 Germany Interventional Cardiology Market Forecast: Revenues ($m), by Segment, AGR (%) and CAGR (%), 2016-2027
Table 7.7 France Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.8 France Interventional Cardiology Market Forecast: Revenues by Segment, ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.9 Italy Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.10 Italy Interventional Cardiology Market Forecast: Revenues by Segment, ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.11 Spain Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.12 Spain Interventional Cardiology Market Forecast: Revenues by Segment ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.13 UK Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.14 UK Interventional Cardiology Market Forecast: Revenues by Segment ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.15 Japan Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.16 Japan Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%) 2016-2027
Table 7.17 Australia Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.18 Australia Interventional Cardiology Market Forecast: Revenues by Segment ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.19 Singapore Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.20 Singapore Interventional Cardiology Market Forecast: Revenues by Segment ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.21 China Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.22 China Interventional Cardiology Market Forecast: Revenues ($m) by Segments, AGR (%) and CAGR (%), 2016-2027
Table 7.23 India Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.24 India Interventional Cardiology Market Forecast: Revenues by Segments ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.25 ROW Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
Table 7.26 ROW Interventional Cardiology Market Forecast: Revenues, By Segments ($m), AGR (%) and CAGR (%), 2016-2027
Table 8.1 Abbott Vascular: Business Overview, 2016
Table 8.2 Abbott Vascular: List of Interventional Cardiology Product Approval
Table 8.3 Edwards Lifesciences: Overview, 2016
Table 8.4 Medtronic Plc: Overview, 2016
Table 8.5 Boston Scientific Group: Overview, 2016
Table 8.6 Sysmetis Overview: 2016
Table 8.7 Cardiac Dimensions Overview: 2016
Table 8.8 Direct Flow Overview: 2016
Table 10.1 Global Pipeline Analysis of PCI Market, 2015-2027
Table 10.2 Global Pipeline Analysis of PCI Market, 2015-2027
Table 10.3 Transcatheter mitral valve repair technology under development, 2016-2027
Table 10.4 Transcatheter mitral valve repair technology under development, 2016-2027
Table 11.1 Leading Countries for Interventional Cardiology Snapshot,2017
List of Figures
Figure 1.1 World Death Number, By Region, 2010
Figure 1.2 World Interventional Cardiology Market Segmentation
Figure 2.1 Percutaneous Coronary Intervention, Procedure
Figure 2.2 Percutaneous Coronary Intervention, Procedure
Figure 2.3 Evolution of Interventional Cardiology
Figure 2.4 Aortic Stenosis
Figure 2.5 Surgical Aortic Valve Surgery
Figure 2.6 Trans-Aortic Valve Surgery (TAVR)
Figure 2.7 Evolution of Trans Aortic Valve Implantation
Figure 2.8 Evolution of Trans Mitral Valve Implantation (TMVR)
Figure 3.1 Global Interventional Cardiology Market: Revenue ($m) by Segment, 2016
Figure 3.2 Global Interventional Cardiology Device: Market Share (%) by Segment, 2016
Figure 3.3 Global Interventional Cardiology Devices Market: Revenue ($m) 2016-2027
Figure 3.4 Global Interventional Cardiology Devices Market by Segment: Market Shares (%), 2016
Figure 3.5 Global Interventional Cardiology Devices Market by Segment: Market Shares (%), 2027
Figure 4.1 Global Percutaneous Coronary Intervention Market by Type: Market Share (%), 2016
Figure 4.2 Global Percutaneous Coronary Stent Market Forecast: Revenue ($m) and AGR (%), 2016-2027
Figure 4.3 Global Percutaneous Coronary Stent Market by Product Type: Market Share (%), 2016
Figure 4.4 Global Percutaneous Coronary Stent Market by Product Type: Market Share (%), 2027
Figure 4.5 Global Bare Metal Stent Market Forecast: Revenue ($m) and AGR (%), 2016-2027
Figure 4.6 Global Drug Eluting Coronary Stent Market Forecast: Revenue ($m) and AGR (%), 2016-2027
Figure 4.7 Global Bioresorbable Vascular Scaffold (BVS) Coronary Stent Market Forecast: Revenue ($m) and AGR (%), 2016-2027
Figure 4.8 Global Percutaneous Coronary Stents Market Share (%), 2015
Figure 4.9 PCI Market: Drivers and Restraints, 2017-2027
Figure 5.1 Global TAVR Market by Revenue ($m) & AGR (%), 2016-2027
Figure 5.2 Global TAVR Market Share Analysis (%), 2015
Figure 5.3 Global TAVR Market Drivers & Restraints, 2016-2027
Figure 6.1 Transcatheter Mitral Valve Market Forecast: 2016-2027 ($m, AGR %)
Figure 6.2 Transcatheter Mitral Valve Market Share Analysis: 2015 (%)
Figure 6.3 Transcatheter Mitral Valve Market Dynamics, 2016
Figure 7.1 Global Interventional Cardiology Market by Country ($m), 2017
Figure 7.2Global Interventional Cardiology Market by Country: Revenues ($m), 2017-2027
Figure 7.3 Global Interventional Cardiology Market by Country: Market shares (%), 2016
Figure 7.4 Global Interventional Cardiology Market by Country: Market Shares(%), 2027
Figure 7.5 US Interventional Cardiology Market by Revenue ($m), AGR (%), 2016-2027
Figure 7.6 Germany Interventional Cardiology Market by Revenue ($m), AGR (%), 2016-2027
Figure 7.7 France Interventional Cardiology Market by Revenue ($m), AGR (%), 2016-2027
Figure 7.8 Italy Interventional Cardiology Market by Revenue ($m), AGR (%), 2016-2027
Figure 7.9 Spain Interventional Cardiology Market by Revenue ($m), AGR (%), 2016-2027
Figure 7.10 UK Interventional Cardiology Market by Revenue ($m), AGR (%),2016-2027
Figure 7.11 Japan Interventional Cardiology Market by Revenue ($m), AGR (%),2016-2027
Figure 7.12 Australia Interventional Cardiology Market by Revenue ($m), AGR (%), 2016-2027
Figure 7.13 Singapore Interventional Cardiology Market by Revenue ($m), AGR (%),2016-2027
Figure 7.14 China Interventional Cardiology Market by Revenue ($m), AGR (%), 2016-2027
Figure 7.15 India Interventional Cardiology Market by Revenue ($m), AGR (%), 2016-2027
Figure 7.16 RoW Interventional Cardiology Market by Revenue ($m), AGR (%), 2016-2027
Figure 8.1 Abbott Vascular Revenues: 2013-2015 ($m)
Figure 8.2 Edwards Lifesciences: Financial Overview, 2013-2015
Figure 8.3 Medtronic Plc.: Financial Overview, 2013-2015
Figure 8.4 Medtronic Plc.: Financial Overview, 2013-2015
Figure 9.1 Global Interventional Cardiology Market: SWOT Analysis, 2016
Figure 9.2 Global Interventional Cardiology Market: STEP Analysis, 2016
Figure 10.1 TAVR Pipeline Market: 2015-2020
3mensio Medical Imaging
Abbott
Accucinch
Alvimedica
Amaranth Medical
Aperture Venture Partners
Arterial Remodelling Technologies
B.Braun
Balton
Biosensors International
Biotronik
Boston Scientific Group
British Heart Foundation
Caisson
Cardiac Dimensions
CardiAQ
Cardica
Cardiosolutions
Centre for Disease and Prevention Control (CDC)
Centres for Medicare & Medicaid Services
Cordis
Direct Flow Medical
Edwards Lifesciences
Elixir Medical Corporation
Emory University
European Society for Cardiology
FDA
HighLife
JenaValve
JW Medical Systems
Kardium
Kyoto Medical Planning
Lepu Medical Technology
Life Science Partners
Mardil Medical
Medfavour Medical Co., Ltd.
Medtronic
Micell Technologies
Microport Scientific
Milipede
Ministry of Health Labor and Welfare (MHLW)
Mitralign Inc.
Mitralix
MitrAssist
MVRx
NCSI
Neovasc
OrbusNeich Medical, Inc.
Paieon Inc
Pharmaceuticals and Medical Devices Agency (PDMA)
Phillips
Reva Medical
Sahajanand Medical Technologies Pvt.
Shanghai MicroPort Medical (Group) Co., Ltd.
Siemens AG
Singapore Heart Foundation
St Jude Medical
Surmodics Inc.
Sysmetis
Tendyne Holdings, Inc.
Terumo
The Health Science Authority (HSA)
The Medical Services Advisory Committee (MSAC)
TransCardiac
Valtech Cardio
Vascular Concepts
Venus Medtech Inc.,
WHO
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
